Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Imagery Rescripting as Treatment for Depression [NA]
A clinical trial is evaluating imagery rescripting as a treatment for depression and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Psilocybin Therapy for Psychological Distress in Palliative Patients [Phase 2]
Phase 2 trial update on psilocybin therapy for psychological distress in palliative patients; status is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Efficacy and Safety of Auricular Acupuncture in Depression During the Covid 19 Pandemic [NA]
A clinical trial evaluating the efficacy and safety of auricular acupuncture for depressive symptoms during the COVID-19 pandemic, currently…
-
FDA approval · 2025-01-17FDA Approved: SPRAVATO — Supplemental Application (Janssen Pharmaceuticals Inc.)
FDA approved a supplemental application for SPRAVATO (esketamine hydrochloride) from Janssen Pharmaceuticals Inc.
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Study on Music Intervention of Non-clinical College Students [NA]
Clinical trial update on music intervention for depression and anxiety among non-clinical college students; the study is currently active bu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Evaluating Clinical Routines for ICBT [NA]
Update on a clinical trial evaluating internet-delivered cognitive behavioral therapy (ICBT) for depression, panic disorder, and social anxi…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD) [Phase 2]
A Phase 2 study evaluating the efficacy and safety of NBI-1065845 in adults with major depressive disorder has completed.
-
FDA approval · 2025-01-15FDA Approved: DESVENLAFAXINE SUCCINATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves the original ANDA for desvenlafaxine succinate (generic) from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Healthy Minds Comparison Study [NA]
A completed clinical trial update for the Healthy Minds Comparison Study investigating depression and anxiety. The provided information does…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Comparing the Effects of Aerobic & Resistance Exercises and Vitamins D & E on Oxidative Stress & Inflammatory Markers Among Patients with Depression [NA]
A clinical trial at Ziauddin University is enrolling to compare aerobic and resistance exercise with vitamins D and E and to assess their ef…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Project VALOR: Veteran Stress and Wellbeing [NA]
A Cornell University–led clinical trial named Project VALOR assessing veteran stress and wellbeing for Alcohol Use Disorder and Depression h…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Primary Prevention of Major Depression in Later Life [NA]
This document reports that a clinical trial studying primary prevention of major depression in older adults has completed.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Brightline: Advancing Mental Health on Campus
Nanyang Technological University is conducting a campus-based clinical trial focused on mental health, currently recruiting to study depress…
-
FDA approval · 2025-01-14FDA Approved: VILAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva's supplemental application for vilazodone hydrochloride, updating the drug's labeling under its existing approval.
-
FDA approval · 2025-01-14FDA Approved: VILAZODONE HYDROCHLORIDE — Supplemental Application (Northstar Rx LLC)
FDA approved Northstar Rx LLC's supplemental application for vilazodone hydrochloride (generic vilazodone).
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Cognitive Flexibility in Depression and TMS Response [NA]
A completed clinical trial investigating cognitive flexibility in major depressive disorder and its relationship with response to transcrani…
-
FDA approval · 2025-01-14FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for escitalopram oxalate from Rising Pharma Holdings, Inc., confirming regulatory approval for the g…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Lifestyle Intervention for Young Adults With Serious Mental Illness [NA]
Completed results posted for a lifestyle intervention trial in young adults with serious mental illness, including schizophrenia, schizoaffe…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Online Peer Support in Long-term Conditions [NA]
King's College London’s online peer support trial for people with long-term physical health conditions and subthreshold depression has compl…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: The Impact of Playing Tetris on Migrants' Mental Health [NA]
The study from Tilburg University is evaluating whether playing Tetris affects PTSD, anxiety, and depression symptoms in migrants. Recruitme…
-
FDA approval · 2025-01-13FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA supplemental approval for ARIPIPRAZOLE by Amneal Pharmaceuticals LLC under an ANDA (ANDA 203906). This document records the supplemental…
-
FDA approval · 2025-01-13FDA Approved: ARIPIPRAZOLE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for aripiprazole by VistaPharm, LLC (ANDA 212870). The authorization pertains to changes to the appr…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Stress and the Sympathetic Nervous System in Adults With Depression [NA]
The document reports the completion of a clinical trial examining stress and the sympathetic nervous system in adults with Major depressive …
-
CLINICAL_TRIALS approval · 2025-01-10Clinical Trial Update: Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
Clinical trial update indicates that duloxetine, sponsored by Eli Lilly, has been approved for marketing in relation to a compassionate-use …
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Acceptability and Feasibility of Cognitive Behavioral Therapy for Treatment-Seeking (CBT-TS) With Deaf Individuals [NA]
A completed ClinicalTrials.gov study evaluating the acceptability and feasibility of cognitive-behavioral therapy for treatment-seeking deaf…